ArticleLeukemia2023
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Open access · hybridAbstract readPublished Erratum
In one paragraph
Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
61 authors at 20 institutions in 13 countries.
Larry Mansouri *Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Birna Thorvaldsdottir *Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-7372-9925
Lesley-Ann Sutton *Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Georgios KarakatsoulisCentre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.
Manja MeggendorferMLL Munich Leukemia Laboratory, Munich, Germany.
Helen ParkerCancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Ferran NadeuInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0003-2910-9440
Christian BrieghelDepartment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-1816-8106
Stamatia LaidouCentre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.ORCID http://orcid.org/0000-0002-4636-1579
Riccardo MoiaDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.ORCID http://orcid.org/0000-0001-7393-1138
Davide RossiDivision of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Mark CatherwoodPatrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Jana KotaskovaDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-1672-7346
Julio DelgadoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Ana E Rodríguez-VicenteCancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.ORCID http://orcid.org/0000-0001-6516-2172
Rocío BenitoCancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.ORCID http://orcid.org/0000-0001-9781-4198
Gian Matteo RigolinHematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Silvia BonfiglioUniversità Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
Lydia ScarfoUniversità Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
Mattias MattssonDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Zadie DavisMolecular Pathology Department, University Hospitals Dorset, Bournemouth, UK.ORCID http://orcid.org/0000-0001-6959-4853
Ajay GogiaAll India Institute of Medical Sciences (AIIMS), New Delhi, India.
Lata RaniAll India Institute of Medical Sciences (AIIMS), New Delhi, India.
Panagiotis BaliakasDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-5634-7156
Hassan Foroughi-AslDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-6925-9040
Cecilia JylhäDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Aron SkaftasonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Inmaculada RapadoHospital Universitario 12 Octubre, Madrid, Spain.
Fatima MirasHospital Universitario 12 Octubre, Madrid, Spain.
Joaquín Martinez-LopezHospital Universitario 12 Octubre, Madrid, Spain.
Javier de la SernaHospital Universitario 12 Octubre, Madrid, Spain.ORCID http://orcid.org/0000-0003-3904-1101
Jesús María Hernández RivasCancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.
Patrick ThorntonHaematology Department, Beaumont Hospital, Dublin, Ireland.
María José LarráyozHematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.
María José CalasanzHematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.
Viktória FésüsHCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Zoltán MátraiCentral Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
Csaba BödörHCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.ORCID http://orcid.org/0000-0002-0729-692X
Karin E SmedbyClinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Blanca EspinetMolecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.ORCID http://orcid.org/0000-0002-4294-8145
Anna PuiggrosMolecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Ritu GuptaAll India Institute of Medical Sciences (AIIMS), New Delhi, India.ORCID http://orcid.org/0000-0001-5364-4086
Lars BullingerDepartment of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Francesc BoschDepartment of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Bárbara Tazón-VegaDepartment of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Fanny Baran-MarszakService d'hématologie Biologique Hôpital Avicenne Assistance Publique des Hôpitaux de Paris, Bobigny, France.ORCID http://orcid.org/0000-0002-3723-2927
David OscierMolecular Pathology Department, University Hospitals Dorset, Bournemouth, UK.
Florence Nguyen-KhacSorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Paris, France.
Thorsten ZenzDepartment of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7890-9845
Maria Jose TerolDepartment of Hematology, INCLIVA Research Insitute, University of Valencia, Valencia, Spain.
Antonio CuneoHematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
María Hernández-SánchezCancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.ORCID http://orcid.org/0000-0001-9968-2782
Sarka PospisilovaDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Ken MillsPatrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0002-6362-4481
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Carsten U NiemannDepartment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-9880-5242
Elias CampoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0001-9850-9793
Jonathan C StreffordCancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0002-0972-2881
Paolo GhiaUniversità Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.ORCID http://orcid.org/0000-0003-3750-7342
Kostas StamatopoulosDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-8529-640X
Richard RosenquistDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. richard.rosenquist@ki.se.ORCID http://orcid.org/0000-0002-0211-8788
Karolinska Institutet · SEUniversidad de Salamanca · ESAll India Institute of Medical Sciences · INSpanish National Cancer Research Centre · ESVita-Salute San Raffaele University · ITBournemouth University · GBCentral European Institute of Technology · CZCopenhagen University Hospital · DKHospital Clínic de Barcelona · ESHospital Del Mar · ESNavarre Institute of Health Research · ESQueen's University Belfast · GBSemmelweis University · HUUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversitat Autònoma de Barcelona · ESUniversity of Ferrara · ITUniversity of Southampton · GBUppsala University · SEBeaumont Hospital · IECentre for Research and Technology Hellas · GR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.